Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Armentum Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
Armentum Partners

Armentum Partners

Operating

Armentum Partners: A financial firm specializing in debt capital solutions for tech and healthcare sectors.

Location
San Francisco, CA, US
Founded
2012
Firm
Compare
Portfolio
Employees
Website

Investments

SPR Therapeutics
SPR Therapeutics

Total Raised

$188.8M

Rounds

14

Debt Financing$60MJanuary 2024
Recover Together
Recover Together

Total Raised

$115M

Rounds

6

Debt Financing$55MJanuary 2023
Lucira Health
Lucira Health
Public

Total Raised

$147.3M

Rounds

11

Post Ipo Debt$80MFebruary 2022
Viome
Viome

Total Raised

$276M

Rounds

8

Debt Financing$20MJanuary 2022
Apeel
Apeel

Total Raised

$719.1M

Rounds

12

Debt Financing$75MJanuary 2022
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals
Public

Total Raised

$410.6M

Rounds

6

Post Ipo Debt$175MJanuary 2022
Coherus BioSciences
Coherus BioSciences
Public

Total Raised

$1.3B

Rounds

17

Post Ipo Debt$400MJanuary 2022
Puma Biotechnology
Puma Biotechnology
Public

Total Raised

$809.3M

Rounds

8

Post Ipo Debt$125MJuly 2021
Clearsense
Clearsense

Total Raised

$125.5M

Rounds

4

Series B$25MJanuary 2021
Viscogliosi Brothers
Viscogliosi Brothers

Total Raised

$70M

Rounds

1

Series D$70MJanuary 2021
Intuity Medical
Intuity Medical

Total Raised

$365.2M

Rounds

19

Debt Financing$57.5MJanuary 2021
Providence Medical Technology
Providence Medical Technology

Total Raised

$101.3M

Rounds

9

Debt Financing$30MJanuary 2021
Aktana
Aktana

Total Raised

$99.2M

Rounds

8

Debt Financing$30MJanuary 2021
Vital Connect
Vital Connect

Total Raised

$178.9M

Rounds

10

Debt Financing$20MJanuary 2021
Sovrn
Sovrn

Total Raised

$121.5M

Rounds

5

Debt Financing$30MJanuary 2021
Glooko
Glooko

Total Raised

$201M

Rounds

8

Debt Financing$100MJanuary 2021
RxSight
RxSight
Public

Total Raised

$236M

Rounds

10

Debt Financing$60MDecember 2020
Getaround
Getaround
Public

Total Raised

$763M

Rounds

20

Debt Financing$25MNovember 2020
FabFitFun
FabFitFun

Total Raised

$255.4M

Rounds

6

Debt Financing$100MJanuary 2020
goTenna
goTenna

Total Raised

$48.5M

Rounds

7

Debt Financing$15MJanuary 2020
BuzzFeed
BuzzFeed
Public

Total Raised

$696.3M

Rounds

11

Debt Financing$50MJanuary 2020
CommonBond
CommonBond

Total Raised

$1.6B

Rounds

11

Debt FinancingJanuary 2020
NeuroPace
NeuroPace
Public

Total Raised

$307.3M

Rounds

10

Debt Financing$60MJanuary 2020
Tophatter
Tophatter

Total Raised

$21M

Rounds

4

Debt FinancingJanuary 2019
ViewRay
ViewRay
Public

Total Raised

$877.8M

Rounds

22

Debt Financing$56MJanuary 2019